Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bon Natural Life (BON) Common Equity (2020 - 2025)

Bon Natural Life (BON) has disclosed Common Equity for 5 consecutive years, with $43.9 million as the latest value for Q3 2024.

  • On a quarterly basis, Common Equity rose 22.02% to $43.9 million in Q3 2024 year-over-year; TTM through Sep 2024 was $43.9 million, a 22.02% increase, with the full-year FY2024 number at $43.9 million, up 22.02% from a year prior.
  • Common Equity was $43.9 million for Q3 2024 at Bon Natural Life, up from $36.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $43.9 million in Q3 2024 to a low of $11.0 million in Q3 2020.
  • A 5-year average of $29.5 million and a median of $30.1 million in 2022 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: soared 140.72% in 2021, then increased 13.41% in 2022.
  • Bon Natural Life's Common Equity stood at $11.0 million in 2020, then skyrocketed by 140.72% to $26.5 million in 2021, then grew by 13.41% to $30.1 million in 2022, then grew by 19.57% to $36.0 million in 2023, then rose by 22.02% to $43.9 million in 2024.
  • Per Business Quant, the three most recent readings for BON's Common Equity are $43.9 million (Q3 2024), $36.0 million (Q3 2023), and $30.1 million (Q3 2022).